Adjunctive Nebulized Antibiotics: What Is Their Place in ICU Infections?
Inhaled antibiotics have been used as adjunctive therapy for patients with pneumonia, primarily caused by multidrug resistant (MDR) pathogens. Most studies have been in ventilated patients, although non-ventilated patients have also been included (but not discussed in this review), and most patients...
Main Author: | Michael S. Niederman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2019.00099/full |
Similar Items
-
Efficacy of adjuvant colistimethate sodium nebulization in ventilator associated pneumonia in pediatric intensive care unit - A randomized controlled study
by: Anil Sachdev, et al.
Published: (2019-01-01) -
Didn’t inhale? Time to reconsider aerosolized antibiotics in the treatment of ventilator-associated pneumonia
by: Daniel A. Sweeney, et al.
Published: (2018-12-01) -
Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
by: J. Rello
Published: (2007-08-01) -
Combined microbiological and clinical outcomes of short-term inhaled colistin adjunctive therapy in ventilator-associated pneumonia
by: Yasser S Nassar, et al.
Published: (2018-01-01) -
Current project of management guidelines of the patients with nosocomial pneumonia in adults
by: Maria A. Karnaushkina, et al.
Published: (2017-07-01)